eliminating the gap between innovation & resources...2nd annual healthcare forum january 10,...

2nd Annual Healthcare forum January 10, 2012 San Francisco, CA

Eliminating the gap between innovation & resources

The global healthcare market is broken and a key issue is the gap between innovators who need money and big players who have money but need innovation.

The Global Leaders is proud to host its 2nd annual healthcare forum on Tuesday, January 10th in San Francisco at the historic Marines’ Memorial Club. The theme for the 2012 event is “Eliminating the Gap Between Innovation & Resources.” The conference will focus on connecting CEOs and other senior executives with institutional investors and business development executives who can help bring the pieces together in a rapidly changing landscape.

• Matching innovation with capital • How to mitigate risks; both financial and regulatory • The future of healthcare in a changing global market

REGISTER NOW Limited Seating – Reserve Early

http://tglhealthcaresymposium.eventbrite.com/

WHO SHOULD ATTEND • Biotech & Pharma • Investors • Business Development • Research Analysts • Key Opinion Leaders • Journalists & Press • Philanthropists • Government Leaders

CONFERENCE CO-CHAIRS

George Bickerstaff Former CFO, Novartis Pharma AG CEO, The Global Leaders

Dr. Margaret Liu Vice Chairman, International Vaccine Institute

location

Marines’ Memorial Club 609 Sutter Street San Francisco, CA 94102 Daytime Symposium 12 noon to 5 pm Reception 6 pm to 9 pm Registration starts at 11 a.m.

The global leaders 2nd annual healthcare forum | January 10, 2012 | san Francisco, ca

Connect | share | evolve

• Network with your global peers - Over 150 senior level executives have already registered

• Learn from the experts; interactive panels focused on - Innovation - Regulatory Issues - Funding - Global Healthcare Trends

• Share your experiences - Round-table discussions facilitated by industry experts

• Listen to key note addresses on - The Need for Innovation - Eldercare and an Aging Population - Life Science Research

• Build on the momentum - Stay connected and continue the dialogue long after the conference has ended

through The Global Leaders network and the connections you make at the conference

3

Fostering collaboration – Luncheon Topics A catered lunch will be served beginning at 12:15 p.m. Each table will be assigned a topic related to the Global Healthcare Challenges we face today and an industry expert who will facilitate the discussion. Make sure that you arrive early to ensure a place at the table of your choice:

CARDIOLOGY Dr. Sarah Samaan Legacy Heart Center CHINA Po Chi Wu Hong Kong University of Science & Technology COMMUNICATIONS Chalmers Fitzpatrick PR Newswire Todd Grossman PR Newswire EUROPE Michael Laznicka Rapid Pharma HEALTHCARE INFORMATON Sean Mehra Health Tap HEALTHCARE POLICY Thomas Loker Author INDIA Parvin Chaturvedi IndUS Anula Jayasuriya Evolve India Life INFECTIOUS DISEASES Britta Wahren Karolinska Institutet INTELLECTUAL PROPERTY David Leitchman Robins, Kaplan, Miller & Ciresi LLP

ONCOLOGY Dr. Elizabeth Chabner-Thompson Radiological Oncologist PATIENT ADVOCACY Aaron Ginn Simplee PHILANTHROPY & HEALTHCARE Nancy Dube ICMEC PRODUCT STRATEGY Mike Rea IDEA Pharma REGULATORY Wendy Goldstein Epstein, Becker & Green, P.C. RESEEARCH Dr. Greg Maguire Bio Regenerative Sciences, Inc. SOCIAL MEDIA Siobhan MacDermott AVG Technologies CZ TECHNOLOGY Robert Bickerstaff AT&T VENTURE CAPITAL Grant Harshbarger M.M. Dillon WOMENS HEALTH Ann Murray-Paige Author


Agenda

11:00 AM Registration

12:00 PM Welcome – George Bickerstaff, The Global Leaders

12:15 PM Catered lunch served and facilitated round-table discussions

1:10 PM Break

1:20 PM Introduction of Panel Topics; Wendy Goldstein, Epstein, Becker & Green

1:25 PM “Innovation in Global Healthcare; are we making progress?”

Panel discussion moderated by Kathleen Sharp, New York Times contributor and acclaimed author

of Blood Feud, a true story about the drug Procrit, Amgen and Johnson & Johnson.

In May 2008, the 61st World Health Assembly adopted Resolution WHA 61.21: Global strategy and plan of

action on public health, innovation and intellectual property. The resolution was comprised of eight elements:

1. Prioritizing research and development needs 2. Promoting research and development 3. Building and improving innovative capacity 4. Transfer of technology 5. Application and management of intellectual property to contribute to innovation and promote

public health 6. Improving delivery and access 7. Promoting sustainable financing mechanisms 8. Establishing and monitoring reporting systems

These elements were designed to promote innovation, build capacity, improve access and mobilize resources.

What progress has been made over the last 3 years? What are the key global healthcare innovations that are on the

horizon? What are the key issues facing cross-border operations and how do they differ by region? What

contributions to solving critical healthcare issues can we expect from Europe, the Pac Rim and the Americas?

Panelists:

Alan Bernstein, Former Founding President, Canadian Institutes of Health Research

Michael Laznika, CEO, Rapid Pharma

Margaret Liu, Vice Chairman, International Vaccine Institute

Garen Staglin, Co-Chairman and Acting CEO, One Mind for Research Campaign

Po Chi Wu, Adjunct Professor, Hong Kong University of Science & Technology

5

Agenda

2:10 PM “Global Healthcare Regulatory Changes and the Impact on Innovation, Pricing, and

Reimbursement in Emerging Healthcare Companies.”

Panel discussion moderated by David Gershon, Senior Partner at Gershon Capital Investment Cie

and Managing Director of M.M. Dillon & Co.

Healthcare is going through a global transition as governments around the world reassess their healthcare

infrastructure and the needs of their society.

As part of this global process regulatory changes in the FDA, SFDA (China), and EMEA as well as other

government agencies in BRIC countries such as Russia, India, and Brazil, are reshaping pricing, reimbursement,

research and development, and access to new bio-pharmaceutical therapies and innovative medical

devices. Understanding this process and identifying the emerging bio-pharma and medical device companies that

will lead this process offers long-term opportunities for investors. As large shifts in the demand for healthcare

emerge from countries with very large populations in emerging markets, healthcare is very likely to be a leading

sector for investment. And this process is likely to be an extended opportunity, given the ever growing middle

class and aging demographics in the emerging markets that will now be able to afford healthcare and will

increasingly need western bio-pharma and medical device products.

Panelists:

Dr. Teo Forcht Dagi, Partner HLM Venture Fund

Dr. Ansbert Gadicke, Managing Director and Co-Founder MPM Capital

Ittai Harel, Partner Pitango Venture Capital

Christopher McFadden, Managing Director Health Evolution Partners

Tim Opler, Founder and Principal Torreya Partners

Dr. Francis Waldvogel, Chairman Novartis Venture Fund

2:55 PM Break




Agenda

3:05 PM “Global Healthcare Companies access to funding and the impact of the unsettled financial

markets.”

Panel discussion moderated by Michiel McCarty, CEO of M.M. Dillon & Co.

The sources of growth capital have migrated from the traditional A, B & C rounds from venture capital followed

by a successful IPO towards a more varied multi-tiered approach involving strategic investors, hedge funds, family

offices, licensing deals and M&A exits.

The identification and access to the now diverse capital formation matrix is a key in the development of healthcare

companies. As more limited partners migrate away from traditional Biotech and healthcare venture funds,

companies are presented with stark choices that need early analysis and board preparation. The role of other

providers of capital and the cost benefit analysis is a topic that is paramount to healthcare companies and their

investors. The process of tapping the varied sources is not fully understood by the marketplace as terms, pricing

and tradeoffs evolve. The mark to market requirements and the unsettled public markets have shifted focus away

from the IPO as the exit towards other more complex alternatives. Build, buy, partner, sell, slow, fast and the

impact on returns and access to capital are the topics of a now more complex decision process.

Panelists:

Michael Rabson, Wilson Sonsini Goodrich & Rosati

Dr. Reinhard J. Ambros, Executive Director, Novartis Venture Funds

Joe Limber, CEO Prometheus Laboratories

Jeff Swarz, Ph.D., Managing Director, M.M. Dillon



7

Agenda

3:50 PM ”A Global Healthcare Perspective: The Reality”

Panel discussion moderated by Siobhan MacDermott, Investor Relations & Chief Policy Officer,

AVG. Ms. MacDermott is also co-author of “Little Bird’s Internet Security Adventure”, a

children’s book designed to keep kids safe online.

We are in a crisis and the decisions we make today will determine the level of healthcare available for generations

to come. Traditionally The Global Healthcare sector has been fairly resilient to recessions, but is not ‘recession

proof’ and the current economic environment is having its impact. While the long-term prospects for the sector

are good, as strong growth in emerging markets, an ageing population, and growing levels of lifestyle-related

chronic diseases in the developed world drive demand; we need to keep focused on bringing innovation and

resources together. It is a fact that new technologies and new marketing strategies are transforming the world of

care delivery globally; we need to continue down this path to ensure that the level of healthcare improves for

everyone.

Panelists:

Harry Kraemer, Executive Partner, Madison Dearborn and former Chairman & CEO, Baxter International

Robert G. Johnson, Jr., M.D., Ph.D.

Myrtle Potter, President, Myrtle Potter & Company

4:35 PM Closing Remarks – Afternoon Session

4:40 PM Extended Break until Evening Reception




Agenda – Optional Networking reception 6p-9p | sponsored by CTPartners

6:00 PM Networking and Cocktail Reception

6:45 PM Welcome – George Bickerstaff, Executive Chairman, The Global Leaders and Brian Sullivan, CEO, CTPartners

7:00 PM “The Need for Innovation in Healthcare”

Dr. Molly Coye, Chief Innovation Officer, UCLA Health Systems

Charged to promote and nurture innovation to improve the quality of care delivered locally and

globally, Dr. Coye will speak about what individuals and organizations can do to promote innovation as a means

to solve the healthcare challenges facing the world.

7:30 PM “An Aging Population and Eldercare”

John Figueroa, CEO, Omnicare

With over 20 years experience in healthcare, Mr. Figueroa is responsible for leading one of the

largest providers of pharmaceutical care for the elderly, Omnicare. He will share his unique perspective on how

the healthcare industry needs to address an aging population.

8:00 PM “Life Science Research – a Perspective from Space”

Mark Sirangelo, Chairman SNC Space Systems

Mark Sirangelo is the Chairman of Sierra Nevada Space Systems, a leading producer of satellites,

propulsion systems and space sub-systems and is also the Executive Vice President of Sierra Nevada Corporation,

a billion dollar aerospace and defense firm. Mr. Sirangelo holds Doctorate, MBA and Bachelor of Science

degrees, has been scientifically published, and has served as an officer in the US Military. He will address the need

for science and technology, including those companies focused on space research, to work together to improve

our healthcare systems.

8:30 PM Networking and Cocktail Reception

9:00 PM Conclusion



9

Distinguished experts & advisors

1

William Adler Communications Consultant Aaron J. Alter Partner, Wilson Sonsini Goodrich & Rosati Dr. Reinhard J. Ambros Executive Director, Novartis Venture Funds Joshua L. Berlin Executive Editor & Director of Business Development, Elsevier Business Intelligence Alan Bernstein Former Founding President, Canadian Institutes of Health Research George Bickerstaff Former CFO, Novartis Pharma AG CEO, The Global Leaders Dr. Elizabeth Chabner-Thompson Radiological Oncologist Dr. Molly Coye Chief Innovation Officer, UCLA Health Systems Dr. Teo Forcht Dagi Partner HLM Venture Fund Nancy Dube EVP and COO, ICMEC John Figueroa CEO, Omnicare Dr. Ansbert Gadicke Managing Director, MPM Capital David Gershon Sr. Partner, Gershon Capital Investments Cie and Managing Director, M.M. Dillon Aaron Ginn Community Development, Simplee

2

Wendy C. Goldstein, J.D. M.P.H. Chair-Health Care and Life Sciences Practices, Epstein Becker & Green Todd Grossman Vice President, PR Newswire Ittai Harel Partner, Pitango Venture Capital Robert G. Johnson, Jr., M.D., Ph.D. Former CEO, Kosan Biosciences Harry Kraemer Executive Partner, Madison Dearborn Former Chairman & CEO, Baxter International Michael Laznicka CEO, Rapid Pharma David Leitchman Partner, Robins, Kaplan, Miller & Ciresi LLP Joe Limber CEO, Prometheus Laboratories Dr. Margaret Liu Vice Chairman, International Vaccine Institute Thomas Loker Author & Retired COO, Ramsell Holding Corporation Siobhan MacDermott Investor Relations and Chief Policy Officer, AVG Technologies CZ Michiel McCarty CEO, M.M. Dillon Christopher McFadden Managing Director, Health Evolution Partners

3

Dr. Greg Maguire CEO, Bio Regenerative Sciences, Inc. Tim Opler Founder and Principal, Torreya Partners Ann Murray Paige Author, Journalist, Filmmaker “The Breast Caner Diaries” Myrtle Potter Founder, Myrtle Potter & CO Michael Rabson Partner, Wilson Sonsini Goodrich & Rosati Mike Rea CEO, IDEA Pharma Dr. Sarah Samaan Co-chair, Echocardiography Laboratory of Legacy Heart Center Kathleen Sharp NYT Contributor and Author Mark Sirangelo Chairman, Sierra Nevada Space Systems Garen Staglin Co-Chairman & Acting CEO, One Mind for Research Campaign Brian Sullivan CEO, CTPartners Jeff Swarz, Ph.D. Managing Director, M.M. Dillon Dr. Francis Waldvogel Chairman, Novartis Venture Fund Po Chi Wu Adjunct Professor, Hong Kong University of Science & Technology


Special thanks to our sponsors

bronze

Gershon Capital & Cie Group50 Consulting Healthy Style Inc. Moo Media

Nivindel, LLC One Mind for Research Remerinc Synergetics

silver

gold

Platinum

DIAMOND

11

LEADERSHIP TEAM Vanessa Alfano Chief Communications and Media Officer [email protected] George Bickerstaff Executive Chairman & Co-Founder [email protected] Jim Gitney Chief Operating Officer & Co-Founder [email protected] Chensun Mills Chief Business Development Officer [email protected] Jayme Porkolab Chief Marketing and Sales Officer [email protected] Ted Pukas Chief Data Services Officer [email protected] David Remer Chief Creative Officer [email protected] Jane Rode Chief Financial Officer [email protected] John Saltarelli Chief Applications Officer [email protected]

The Global Leaders is a digital community for CEOs and other senior-level

executives in business, government, education and philanthropy. The Global

Leaders has 2 million members who have held senior executive leadership

positions in companies that drive more than 70 percent of the world’s Gross

Domestic Product.

Our Healthcare Forum is a product of TGL InPersonTM events, which allow

our members to connect and network face-to-face through industry specific

conferences, product launches, investor relations seminars or private

receptions. TGL’s Event Planning Staff not only coordinates our company

sponsored events, but also are available to help with the planning and

promotion of customized events for our members and their organizations.

Other services that The Global Leaders provide include:

• Ask the Global ExpertTM allows members to ask a question to people inside our network

• TGL MoneyTM provides our members with the ability to summarize investment capital that they or their company may have to offer

• TGL DealsTM offers a platform for members to share deals they are sponsoring or feel would be of value to other members

• TGL ONEonONETM provides our members an option to work with a TGL Professional for customized solutions for their business needs, which include Market Research, Professional Services, Executive Recruitment, Data Services and Marketing Expertise

By the end of the year we will launch our new website which will showcase our

new branding and offer enhanced member services. To learn more about The

Global Leaders contact a member of our leadership team or visit

http://www.tgleaders.com or our blog at

http://www.tgleaders.blogspot.com

eliminating the gap between innovation & resources...2nd annual healthcare forum january 10,...

Documents